WO2025201511 - INDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/201511
Publication Date
02.10.2025
International Application No.
PCT/CN2025/085719
International Filing Date
28.03.2025
Title **
[English]
INDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
DÉRIVÉ D'INDAZOLE ET SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
吲唑衍生物及其制备方法与应用
Applicants **
SHANGHAI JINGXIN BIOMEDICAL CO., LTD.
ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.
Inventors
BAO, Ziyang
GE, Xiaojun
CHEN, Lei
Priority Data
202410381526.2
29.03.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2170 | |
| EPO | Filing, Examination, Granting | 13438 | |
| Japan | Filing, Examination, Granting | 2174 | |
| South Korea | Filing, Examination, Granting | 2115 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
25,237
Contact Us
Abstract[English]
The present invention relates to an indazole derivative and a preparation method therefor and a use thereof. The indazole derivative can be used for LRRK2 kinase inhibition or for treating Parkinson's disease (PD).[French]
La présente invention concerne un dérivé d'indazole et son procédé de préparation et son utilisation. Le dérivé d'indazole peut être utilisé pour l'inhibition de la kinase LRRK2 ou pour le traitement de la maladie de Parkinson (PD).[Chinese]
涉及吲唑衍生物及其制备方法与应用，所述吲唑衍生物可用于LRRK2激酶抑制，或用于治疗帕金森病（PD）。